Our study encourges the use of ancillary markers such as Ki67 and reticulin histochemistry in the workup of evaluations of adrenocortical neoplasms, which are efficient, reproducible and easy-to-apply. This evidence concerns the gene MKI67 and adrenal cortex neoplasm.